Status:
COMPLETED
Effectiveness of Telehealth Program in Patients With Type 2 Diabetes
Lead Sponsor:
Muğla Sıtkı Koçman University
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Diabetes education is of great importance in the effective management of diabetes. Studies have shown that patients given diabetes education have positive developments in their ability to manage the d...
Detailed Description
The use of telehealth technologies in the field of health is becoming more and more widespread. Telehealth has become one of the frequently used options in the follow-up process of chronic diseases su...
Eligibility Criteria
Inclusion
- Having a diagnosis of type 2 diabetes mellitus for at least 6 months,
- Those between the ages of 18-65,
- Receiving oral antidiabetic and/or insulin therapy,
- Having a mobile phone capable of receiving and playing video messages,
- Does not have hearing, speech and psychiatric problems that prevent communication,
Exclusion
- Individuals who do not volunteered to participate in the study
- Patients who have hearing, speech and psychiatric problems that prevent communication
Key Trial Info
Start Date :
January 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05202470
Start Date
January 6 2022
End Date
May 15 2023
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Muğla Training and Research Hospital
Muğla, Turkey (Türkiye), 48000